Ohio study aims to beat lung cancer with smarter testing
NCT ID NCT03199651
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This large study in Ohio is looking at whether advanced genomic testing and immunotherapy decision support can help people with stage IV non-small cell lung cancer live longer and have a better quality of life. Researchers will compare standard care with a more personalized approach that uses tumor and blood samples to guide treatment. The study also includes support for smoking cessation and tracks costs to see if the approach is worth it.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could show that personalized treatment decisions based on genomic testing improve survival and quality of life for people with advanced lung cancer.
- What could go wrong
- This is an observational and randomized study, not a test of a new drug. Results depend on many factors, and improvements may be modest or not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIGARETTE SMOKER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Ohio State University Comprehensive Cancer Center
RECRUITINGColumbus, Ohio, 43210, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI be a Pathologist's second opinion?
- Personalized cancer care: genetic analysis may unlock targeted treatments for advanced lung cancer
- Smartphone prompts timed to mood may boost quitting efforts
- Blood tests could unlock early clues for three major lung diseases
- New biologic drug DBC-664 takes aim at Hard-to-Treat cancers
- Genetic roadmaps for advanced cancer: study tests whether expert navigation boosts targeted therapy use